Celladon Corp (CLDN) 26.28 $CLDN 'Mad Money' Lightning

New Post Public Reply Private Reply Replies (0) Message Board

Mar 21, 2015 at 9:23 PM

Celladon Corp (CLDN) 26.28 $CLDN

'Mad Money' Lightning Round: Buy, Buy, Buy Whole Foods Markets
at The Street - Sat Mar 21, 5:00AM CDT
Cramer likes Celladon and Sirius XM Radio, thinks Centene is amazing and is avoiding King Digital and Virgin America.
WFM: 53.97 (+0.35), CNC: 70.25 (-0.34), TTWO: 25.68 (-0.04), SAVE: 79.79 (-0.16), VA: 32.20 (-0.18), ACHN: 11.06 (-0.36), DD: 74.34 (-0.17), CLDN: 26.28 (-0.98), AAL: 55.76 (+0.57), SIRI: 3.98 (+0.02), LUV: 46.36 (+0.01), KING: 15.10 (+0.42)

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Mar 20, 7:24PM CDT
Cramer says it's time to take some profits and raise cash for the next speed bump. He'll be watching company earnings from Sonic, Paychex and GameStop, among others.
MKC: 72.88 (+0.48), NKE: 101.98 (+3.66), BBRY: 9.51 (-0.19), CLDN: 26.28 (-0.98), PVH: 102.44 (+0.81), LUV: 46.36 (+0.01), PAYX: 51.62 (+0.38), SAVE: 79.79 (-0.16), VA: 32.20 (-0.18), SONC: 34.19 (+0.45), DPZ: 104.63 (+0.86), DD: 74.34 (-0.17), AAL: 55.76 (+0.57), PRTA: 38.66 (+9.43), SIRI: 3.98 (+0.02), KING: 15.10 (+0.42), WFM: 53.97 (+0.35), GME: 40.92 (+0.13), GIII: 111.89 (+0.84), FIVE: 31.86 (+0.49), FINL: 24.00 (+0.08), LULU: 65.74 (+1.34), DRI: 66.75 (+1.88), CNC: 70.25 (-0.34), TTWO: 25.68 (-0.04), FRSH: 16.49 (+0.02), ACHN: 11.06 (-0.36)

Nasdaq stocks posting largest percentage increases
AP - Fri Mar 20, 12:25PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
BIIB: 475.98 (+42.33), GLMD: 13.25 (+1.60), HIIQ: 9.13 (-0.11), VTAE: 12.36 (+1.70), CLDN: 26.28 (-0.98), ATRA: 38.78 (+2.89), VBLT: 5.75 (+1.01), CORT: 5.60 (-0.25), FPRX: 24.79 (-1.18)

Celladon Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire - Mon Mar 16, 6:00AM CDT
Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene therapy, today announced that on March 9, 2015 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options to purchase a total of 40,000 shares of common stock to three new employees, with two of such grants having a grant date of March 9, 2015 (the "March 9 Grants"

and the third having a grant date of March 11, 2015 (the "March 11 Grant"

, with each such grant date corresponding to the employees' respective hire dates.
CLDN: 26.28 (-0.98)

Could This Clinical-Stage Biotech Stock Soar in April?
George Budwell, The Motley Fool - Motley Fool - Thu Mar 12, 7:59AM CDT
Biotech stocks are known for their wild ways. Over the last few years, for instance, we have witnessed dozens of small-cap companies soar -- as well as sink -- following pivotal clinical or regulatory catalysts. Perhaps one of the most intriguing...
BLUE: 124.76 (-1.64), ICPT: 290.98 (+2.47), CLDN: 26.28 (-0.98)

Nasdaq stocks posting largest volume increases
AP - Fri Mar 06, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
ICEL: 7.71 (-0.39), GILT: 5.70 (+0.06), CLDN: 26.28 (-0.98), ITCI: 27.64 (+1.30), DRRX: 1.68 (-0.01), DRAD: 4.54 (-0.10)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 11:45AM CST

SSH: 4.00 (-0.08), ONCY: 0.81 (-0.02), LTM: 70.75 (-0.01), LEDS: 0.79 (-0.01), CLDN: 26.28 (-0.98), AXN: 1.72 (-0.15), EXAS: 24.18 (-0.20), DRRX: 1.68 (-0.01), DRAD: 4.54 (-0.10), BLRX: 2.06 (+0.03), GENE: 3.88 (-0.09), OREX: 7.19 (-0.41), ICEL: 7.71 (-0.39), BORN: 1.09 (-0.06), DMD: 5.66 (-0.26), AVEO: 1.35 (-0.16), CALA: 15.75 (+1.68), MTL: 1.15 (-0.12), CKP: 10.72 (+0.17), ERII: 2.85 (-0.15)

Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 8:15AM CST

NGL: 26.68 (+0.03), FNSR: 23.24 (+0.79), SSH: 4.00 (-0.08), YY: 56.19 (+2.03), CNAT: 6.24 (-0.33), ASTI: 1.30 (-0.01), CLDN: 26.28 (-0.98), AXN: 1.72 (-0.15), VMEM: 3.52 (+0.27), BLRX: 2.06 (+0.03), GENE: 3.88 (-0.09), OREX: 7.19 (-0.41), SKUL: 11.04 (+0.18), CALA: 15.75 (+1.68), AVEO: 1.35 (-0.16), MSO: 6.27 (+0.08), GALE: 1.46 (-0.03), CKP: 10.72 (+0.17)

Will Celladon (CLDN) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 05, 6:52AM CST
Will Celladon (CLDN) Continue to Surge Higher?
CLDN: 26.28 (-0.98)

Latest Updates on Health Care Sector: Special Research on bluebird bio, Brainstorm, CASI Pharmaceuticals, Celladon, and Cellular Dynamics
PR Newswire - Mon Feb 16, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
BLUE: 124.76 (-1.64), ICEL: 7.71 (-0.39), CLDN: 26.28 (-0.98), CASI: 1.46 (-0.05), BCLI: 4.45 (+0.14)

Why Earnings Season Could Be Great for Celladon (CLDN) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 7:55AM CST
Celladon has a favorable Zacks Rank and an ESP in positive territory, thus investors might want to consider this stock ahead of earnings
CLDN: 26.28 (-0.98)

Which Biotech Stock Should Pfizer, Inc. Buy?
Motley Fool Staff, Brian Orelli, Leo Sun, and George Budwell - Motley Fool - Sun Feb 08, 7:02AM CST
Source: Pfizer. Pfizer is struggling to offset slowing sales tied to expiring patents, and that has some observers thinking that Pfizer remains on the hunt to buy another drugmaker that can spark its growth. Earlier this week, Pfizer announced...
BIIB: 475.98 (+42.33), PFE: 34.25 (+0.10), AMGN: 170.10 (+0.99), CLDN: 26.28 (-0.98), BMY: 67.76 (-0.56), GSK: 48.81 (+0.60), CELG: 128.50 (+3.17), SGEN: 38.86 (-0.83), GILD: 102.29 (+0.85), AZN: 72.70 (+1.80), MRK: 58.58 (+0.37)

14 IPOs You Wish You Bought in 2014 (And Made a Killing On)
at The Street - Thu Feb 05, 7:36AM CST
Getting in on a hot IPO may prove difficult for most retail investors. That doesn't mean there aren't gains to be made. Here are the best performing IPOs in 2014.
ZFGN: 46.94 (-4.40), GPRO: 40.40 (+0.87), CLDN: 26.28 (-0.98), ZEN: 22.17 (-1.24), ASPX: 79.99 (-6.73), TNET: 36.25 (+0.28), NVRO: 50.31 (+0.30), OCUL: 42.50 (+0.30), RDUS: 48.61 (+0.41), ALDR: 29.01 (-0.44), IRMD: 14.49 (-0.11), KITE: 71.89 (-1.62), TUBE: 13.04 (+0.49), VBLT: 5.75 (+1.01)

Celladon Corporation to Present at the BIO CEO & Investor Conference
GlobeNewswire - Tue Feb 03, 6:13AM CST
Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene therapy, today announced that the Company will provide a corporate update and overview at the BIO CEO & Investor Conference, being held at the Waldorf-Astoria hotel in New York City on February 9-10, 2015.
CLDN: 26.28 (-0.98)

3 Clinical-Stage Biotech Stocks with Explosive Upside Potential in 2015
George Budwell, The Motley Fool - Motley Fool - Sat Jan 10, 1:07PM CST
Source: Flickr via Idaho National Laboratory. Biotech stocks have the uncanny ability to absolutely crush it following a positive clinical or regulatory catalyst. And this trend has been especially pronounced among standout clinical-stage...
BLUE: 124.76 (-1.64), DVAX: 22.62 (-0.57), HTGC: 13.98 (+0.33), NVAX: 9.58 (-0.13), PFE: 34.25 (+0.10), MRK: 58.58 (+0.37), AZN: 72.70 (+1.80), CLDN: 26.28 (-0.98), GSK: 48.81 (+0.60)

Celladon's Cardiovascular Fast Track MYDICAR Candidate Could Provide Upside
Stock Reversals - Seeking Alpha - Wed Jan 07, 4:10PM CST
We believe Celladon (NASDAQ: CLDN ) has the potential to be a wealth builder for early investors ahead of its April Phase 2b data release. The company has been increasing credit lines, setting up manufacturing agreements and running test batches ...
CLDN: 26.28 (-0.98)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Minesto Teams Up to Unlock Tidal Power in Maldives

The world of ocean energy just got a jolt from an unlikely corner. Minesto, the ocean energy whiz, and Morteza Capital, a savvy investment force entrenched in the Maldives, are shaking hands to usher tidal energy into this paradise. Tidal Waves Meet Tourism When you're talking about the Maldives, you're talking about two main things: pristine tropical getaways and a whole...

P.C. Richard & Son: 117 Years of Thanksgiving Tradition

In today's cutthroat retail world, where every dollar counts, you won't see many shops in a rush to shutter their doors on a busy shopping day unless they mean business. So here's a rare bird: P.C. Richard & Son, the family-owned retail stalwart, has a different tune to hum amid the holiday hustle—closing every single one of their 63 stores for Thanksgiving. Figure...

Gildan Activewear Faces Major Class Action Lawsuit

Investors Turn Against Gildan Activewear Ever see a freight train barreling down the track? That's what it feels like when a class action lawsuit rears its head against a behemoth like Gildan Activewear Inc. (NYSE: GIL). After years of allegedly pulling the wool over investors' eyes, those same investors are now being called to muster—their chance to lead a charge of...

Aktonomy 2026: Tackling New AI Security Frontiers

Cracking Open the AI Security Code Today's tech landscape feels like a high-stakes game of chess. Akto's Aktonomy Fall '26, scheduled for October 27, 2026, is set to put the biggest AI security challenges under the microscope. In the world of security, there's no room for dithering, and Akto knows it. This event aims to dive deep into the concepts that enterprise security...

Navigating Headstone Choices Beyond Cemetery Norms

Decoding Headstone Purchases: A Monumental Decision Headstones may not be on everyone's mind until they're suddenly front and center—a task during a time filled with emotions. Contrary to what many folks believe, the cemetery isn't the sole option for purchasing these memorials. The traditional route has always included cemeteries peddling everything you might need in...

Miranda Lambert Lights Up Red Kettle Campaign

By Logan Wright Updated Oct 25, 2026 Category News Views 398

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Clarins Dazzles Austin with Skin Longevity Event

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Abu Dhabi's Youth Orchestra: A Cultural Revolution

A New Dawn for Abu Dhabi's Musical Future Abu Dhabi's making some noise, and I don't mean just any kind of noise. We're talking about a symphony of opportunity. The Department of Culture and Tourism – Abu Dhabi just dropped big news—setting up a dedicated institution for the Youth Orchestra Abu Dhabi. This ain't just a pat on the cultural back; it's a whole new ball...

Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Bank of America Faces Legal Battle Over Compliance Failures

Another Day, Another Lawsuit Just when you thought the financial waters were calm, there's a storm brewing for Bank of America Corp. (NYSE: BAC). They've been slapped with a securities class action lawsuit that screams all kinds of regulatory and compliance failures. You’d think with all that cash flow, BAC could afford to run a tight ship. But apparently, they decided...